Drug Shortage Report for APO AMPI CAPSULES 250MG

Last updated on 2017-10-05 History
Report ID 19582
Drug Identification Number 00603279
Brand name APO AMPI CAPSULES 250MG
Common or Proper name AMPICILLIN
Company Name APOTEX INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMPICILLIN
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL & 1000 BTL
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-08-16 French Compare
v1 2017-08-16 English Compare

Showing 1 to 2 of 2